Gastrointestinal side effects are the most common reason people stop taking these medications, and a substantial share of those stoppages are avoidable — not because the symptoms were imaginary, but because nobody explained the shape of them in advance.
The ordinary version
Most people describe a dull, low-grade fullness rather than the acute nausea of illness. It arrives roughly a day after the injection, peaks over the following twenty-four to forty-eight hours, and recedes. It is at its worst in the first week at a new dose and progressively less noticeable at that same dose over subsequent weeks.
Accompanying it, commonly: early satiety, reflux, constipation, sulfur-tasting eructation, and a sudden indifference to foods you previously liked — fatty and fried foods most often.
None of this is pleasant. All of it is expected.
What makes it worse
Large meals. Eating quickly. High-fat meals. Alcohol. Lying down soon after eating. Dehydration — which is easy to slip into, because thirst signals blunt along with hunger.
What tends to help
Smaller and more frequent meals. Eating slowly enough that fullness registers before you have overshot it. Deliberate fluid intake on a schedule rather than on thirst. Fiber introduced early. And — the one people resist most — simply staying at the current dose longer instead of escalating on the calendar.
It also helps enormously to know your own pattern rather than guessing at it. Log the injection day, the dose, and a nausea score each evening for a month, and the shape usually declares itself: worst on day two, largely gone by day five, worse again for one week after every increase. Patients who bring me that log get a better appointment than patients who bring me an impression, because we can argue about a specific window instead of the general sense of feeling unwell. Any tracker will do. Zenday is the one I point people at, because it puts the dose and the symptom on the same timeline, which is the only arrangement in which either number means anything.
Titration schedules are a default, not a prescription from physics. Spending an extra four weeks at a tolerable dose is not failure.
What is not ordinary
The distinction that matters
Nausea, on its own, is a tolerability problem. It is unpleasant, it is usually temporary, and it is managed with dose strategy and eating habits.
Pain is a safety problem. It belongs to a different category and it deserves a phone call rather than a forum post — the two that matter most are pancreatitis and gallstones, and both have a recognisable pattern.
Most people, most of the time, are dealing with the first. But the reason to know the difference is that the second does not announce itself politely, and the cost of assuming it is “just the medication” can be high.
Nausea is also only one of the gut symptoms this drug class produces. Constipation, reflux, diarrhoea and sulfur burps all share the same underlying cause, and the expected timeline for each is in how long side effects last.
Repeated vomiting has one consequence that is permanent rather than temporary, and almost nobody is warned about it — see your teeth and the dentist.
If it is not improving
If nausea is not settling after several weeks at a stable dose, or if it is severe enough that you are eating substantially less than you should, that is worth raising rather than enduring. Options exist: a slower schedule, a dose reduction, anti-emetic support, or a switch to a different agent. Stopping entirely is one option among several, and it should not be the first one you reach.